Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Lilly to acquire biopharma company DICE Therapeutics in $2.4bn deal Eli Lilly and Company (Lilly) has agreed to acquire US-based biopharmaceutical company DICE Therapeutics, listed on the Nasdaq,… byPallavi MadhirajuJune 20, 2023